Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial
Titel:
Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial
Auteur:
Mahomed, Sharana Garrett, Nigel Capparelli, Edmund V Osman, Farzana Mkhize, Nonhlanhla N Harkoo, Ishana Gengiah, Tanuja N Mansoor, Leila E Baxter, Cheryl Archary, Derseree Yende-Zuma, Nonhlanhla Samsunder, Natasha Carlton, Kevin Narpala, Sandeep McDermott, Adrian B Doria-Rose, Nicole A Moore, Penny L Morris, Lynn Abdool Karim, Quarraisha Mascola, John R Abdool Karim, Salim S